SAN DIEGO, Calif. – December 5, 2007 – Pharmatek Laboratories, Inc. today announced the launch of Pharmatek University (Pharmatek UT), a continuing education program for drug development scientists.
Pharmatek University is designed to provide a forum of scientific exchange for the local biotechnology and pharmaceutical industry. Topics focus on drug development and pharmaceutical technology. Seminars will cover issues such as analytical chemistry, formulation development, GMP manufacturing, toxicology, PK/ADME, drug safety, design of clinical trials, regulatory affairs, and drug delivery and pharmaceutical technology.
“Pharmatek U has always been a part of our corporate culture, a sort of continuing education program for Pharmatek scientists,” said Timothy Scott, president of Pharmatek. “The Pharmatek U Seminar Series represents a forum that all of us in the broader San Diego pharma community can participate in – a way of educating ourselves on a wide range of drug development topics and best practices. The program is designed to enhance scientists’ understanding of drug development, allowing them to move drug candidates through the clinic faster and more effectively.”
Seminars are held from 8:00 a.m. to 9:00 a.m. at Pharmatek Laboratories located at 7330 Carroll Road, San Diego, California 92121. Sessions are open to all interested in drug development at no cost. For information and to register, visit PTEK U or contact Elizabeth Hickman at (858) 805-6383.
The first seminar in this series is scheduled for Thursday, December 6, 2007. Robert Ternansky, Ph.D., former senior vice president, chemistry for Attenuon, LLC, will present “Selecting and Managing a Contract Research Organization.”
Future speakers include Judy Senior of Senior Consulting who will present on the topic of parenteral drug delivery and Jeff Schwegman of BioConvergence who will present on the topic of protein drug development.Leave a reply →